Chester County News and Community Website
MyChesCo is the perfect source for businesses in Philadelphia to stay informed and up-to-date with the latest business news. We provide essential information to help businesses grow, network, and hire. Our content is concise and objective, making it easy to stay informed and make well-informed decisions.
MyChesCo provides comprehensive Philadelphia business news, giving you the latest information and updates about local businesses. Our content features news about upcoming events, articles, and resources to help businesses grow and expand. We provide in-depth coverage of relevant topics and trends in the local business community, making it easy to stay informed and up-to-date.
MyChesCo also features resources to help businesses network and hire. Our content focuses on helping businesses connect with each other and build relationships. We also provide resources to help businesses find new hires and fill job openings. We make it easy for Philadelphia businesses to network and find the best talent to move their businesses forward.
Our content is comprehensive and accessible, making it easy for businesses in Philadelphia to find the information they need. Our content is updated regularly, giving you the most up-to-date news and information about local businesses. We provide concise and objective content, making it easy to stay informed and make well-informed decisions about your business.
PHILADELPHIA, PA — Estancia Capital Management closed its third buyout fund with $367 million in investor commitments, exceeding its $350 million target and signaling continued appetite for specialized private equity …
Estancia Capital Raises $367 Million Fund Amid Private Equity Slowdown Read More
PHILADELPHIA, PA — The Urban League of Greater Philadelphia has begun construction on an $8 million community center and headquarters in West Philadelphia, a project aimed at expanding access to …
Urban League Breaks Ground on $8 Million Community Hub Read More
PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) has asked the U.S. Food and Drug Administration to grant Rare Pediatric Disease Designation for SkinJect, its experimental treatment for patients with …
Medicus Seeks FDA Rare Disease Status for Skin Cancer Therapy Read More
PHILADELPHIA, PA — Rita’s Italian Ice & Frozen Custard is introducing a limited-time Mermaid Italian Ice flavor nationwide as the frozen-dessert chain expands its seasonal menu during the peak summer …
Rita’s Adds Limited-Time Mermaid Flavor to Summer Menu Read More PHILADELPHIA, PA — Enradius says it has compiled a location-verified audience of more than 1 million cannabis consumers across Pennsylvania, Maryland, and Delaware, highlighting how marketers are increasingly using geolocation …
Enradius Builds 1 Million-Device Cannabis Audience for Advertisers Read More
PHILADELPHIA, PA — Future Standard has closed a $3 billion private equity secondaries fund, the largest fundraising effort in the firm’s more than 30-year history, positioning the alternative asset manager …
Future Standard Raises $3 Billion for Secondaries Fund as Market Activity Surges Read More PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) has submitted an application to health regulators in Abu Dhabi to begin a genomics-based Phase 2a study of its investigational drug Teverelix …
Medicus Seeks UAE Approval for Genomics-Based Endometriosis Trial Read More PHILADELPHIA, PA — Exyn Technologies (NASDAQ: EXYN, EXYNW) has expanded the capabilities of its ExynAI software platform, adding automation, data-processing and quality-control features aimed at reducing the time required to …
Exyn Expands Mapping Software as Demand Grows for Automated Workflows Read More
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) granted stock options covering 146,000 shares to a newly hired employee under a Nasdaq inducement award provision, a compensation mechanism commonly used …
Context Therapeutics Grants New-Hire Equity Award Under Nasdaq Rule Read More
PHILADELPHIA, PA — Century Therapeutics (Nasdaq: IPSC) reported new preclinical data supporting its experimental type 1 diabetes therapy CNTY-813, as the biotechnology company works toward a planned Investigational New Drug …
Century Therapeutics Advances Diabetes Cell Therapy Toward 2026 FDA Filing Read More